Lyell Immunopharma, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lyell Immunopharma, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Lyell Immunopharma, Inc. Operating Margin for the quarter ending September 30, 2024 was -345K %, a 82534% decline year-over-year.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2023 was -190K %, a 85918% decline from 2022.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2022 was -221 %, a 89% increase from 2021.
  • Lyell Immunopharma, Inc. annual Operating Margin for 2021 was -2.02K %, a 26.2% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -190K -190K -85918% Jan 1, 2023 Dec 31, 2023
2022 -221 +1.8K +89% Jan 1, 2022 Dec 31, 2022
2021 -2.02K +716 +26.2% Jan 1, 2021 Dec 31, 2021
2020 -2.73K +12.8K +82.4% Jan 1, 2020 Dec 31, 2020
2019 -15.5K Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.